Trial intelligence / Profile preview

Influence of methylphenidate on sleep and circadian rhythm in children with ADHD

2007-004664-46Phase 4Active

Sponsor
No Sponsor
Start
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and sleep disorder, sponsored by No Sponsor. Primary endpoints: Sleep latency, Sleep onset time and 3 more. Started Nov 2007; status: active.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)sleep disorder

Beyond the preview

Go deeper on 2007-004664-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004664-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call